Lactobacillus reuteri for Bloating and Intestinal Gas
B Good Evidence At least one randomized trial supports this, with mostly consistent results.Multiple RCTs in breastfed infants show reduced crying time (50-70 min/day reduction). Well-established evidence for infantile colic but limited to infant population.
The Bottom Line
Multiple RCTs in breastfed infants show reduced crying time (50-70 min/day reduction). Well-established evidence for infantile colic but limited to infant population.
Key Study Findings
Population: Adults with NAFLD diagnosed via FibroScan
Population: Adults with functional constipation
Population: Adults with functional bloating
Population: Children with H. pylori infection
Population: Children aged 6-15 with functional abdominal pain
Key Statistics
7
Studies
500
Participants
Positive
Grade
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Commonly Used Dosages
- general:
- 100 million - 5 billion CFU/day
- infantilecolic:
- 100 million CFU/day (DSM 17938 strain, 5 drops)
- adultgisupport:
- 1-5 billion CFU/day
Upper limit: Well-tolerated up to 10 billion CFU/day in clinical trials
Dosages Studied in Research
| Dosage | Duration | Effect | N |
|---|---|---|---|
| Lactobacillus reuteri E9 (dose not specified) | -- | Positive | -- |
| None | -- | Positive | 65 |
| 4x10^8 CFU (induction), 2x10^8 CFU (standard) | 15 weeks | Positive | 56 |
| None | -- | Positive | 54 |
| None | -- | Positive | 3122 |
| L. reuteri DSM 17938 (1e8 CFU twice daily) | 16 weeks | Positive | 101 |
| None | 4 weeks | Positive | -- |
Best taken: Before meals or on empty stomach; for infants, add drops to breast milk or formula
Safety & Side Effects
Reported Side Effects
- ⚠ Mild gas in initial days of use
- ⚠ Occasional increased fussiness in infants during adjustment (transient)
- ⚠ Rare loose stools
- ⚠ Very rare: bacteremia in immunocompromised individuals
Known Interactions
- ● Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
- ● Immunosuppressants (theoretical risk in immunocompromised patients)
- ● Proton pump inhibitors (altered gastric pH may affect colonization)
Tolerable upper intake: Well-tolerated up to 10 billion CFU/day in clinical trials
Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Does Lactobacillus reuteri help with Bloating and Intestinal Gas?
How much Lactobacillus reuteri should I take for Bloating and Intestinal Gas?
Are there side effects of Lactobacillus reuteri?
How strong is the evidence for Lactobacillus reuteri and Bloating and Intestinal Gas?
Related Evidence
Other ingredients for Bloating and Intestinal Gas
Lactobacillus reuteri for other conditions
References
- [1] Yongcheng Jiang et al.. Front Biosci (Landmark Ed). 2025. Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA. doi:10.31083/FBL39587 PubMed
- [2] Shamim Naizr et al.. Euroasian J Hepatogastroenterol. 2025. Incidence and Characterization of SIBO in NAFLD Patients. doi:10.5005/jp-journals-10018-1468 PubMed
- [3] G Riezzo et al.. Benef Microbes. 2018. Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation. doi:10.3920/BM2017.0049 PubMed
- [4] Ovidiu Burta et al.. Transl Gastroenterol Hepatol. 2018. Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical … doi:10.21037/tgh.2018.09.11 PubMed
- [5] Jue-Rong Feng et al.. Eur J Clin Pharmacol. 2017. Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis. doi:10.1007/s00228-017-2291-6 PubMed
- [6] Zvi Weizman et al.. J Pediatr. 2016. Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. doi:10.1016/j.jpeds.2016.04.003 PubMed
- [7] Behnaz Amirimani et al.. Middle East J Dig Dis. 2013. Probiotic vs. Placebo in Irritable Bowel Syndrome:A Randomized Controlled Trial. PubMed
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.